Phase II Trial of ART + Dual bNAbs vs. ART + Placebo During Primary HIV-1 Infection-impact on Post-ART Control
Clinical trial NCT05300035 · RECRUITING
Trial details
- NCT number
- NCT05300035
- Sponsor
- ANRS, Emerging Infectious Diseases
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-11
- Primary completion
- 2026-12-10
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.